4.7 Letter

Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure

Related references

Note: Only part of the references are listed.
Editorial Material Infectious Diseases

Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)

B. A. Cunha et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)

Review Pharmacology & Pharmacy

Telavancin: A novel lipoglycopeptide antimicrobial agent

Ryan J. Attwood et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)